| Target Price | $144.84 |
| Price | $124.75 |
| Potential | 16.10% |
| Number of Estimates | 15 |
| 15 Analysts have issued a price target Paychex 2026 . The average Paychex target price is $144.84. This is 16.10% higher than the current stock price. The highest price target is $160.65 28.78% , the lowest is $125.83 0.86% . | |
| A rating was issued by 21 analysts: 1 Analysts recommend Paychex to buy, 15 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Paychex stock has an average upside potential 2026 of 16.10% . Most analysts recommend the Paychex stock at Hold. |
17 Analysts have issued a sales forecast Paychex 2026 . The average Paychex sales estimate is $6.7b . This is 15.10% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $6.9b 19.83% , the lowest is $6.3b 9.56% .
This results in the following potential growth metrics:
| 2025 | $5.6b | 5.56% |
|---|---|---|
| 2026 | $6.7b | 19.68% |
| 2027 | $7.1b | 6.07% |
| 2028 | $7.5b | 5.84% |
| 2029 | $8.0b | 6.47% |
| 2030 | $8.4b | 5.50% |
11 Analysts have issued an Paychex EBITDA forecast 2026. The average Paychex EBITDA estimate is $3.1b . This is 19.48% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.4b 30.94% , the lowest is $2.9b 9.40% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $2.4b | 1.25% |
|---|---|---|
| 2026 | $3.1b | 29.75% |
| 2027 | $3.4b | 8.47% |
| 2028 | $3.7b | 7.46% |
| 2029 | $3.9b | 5.87% |
| 2030 | $4.0b | 4.13% |
| 2025 | 43.43% | 4.08% |
|---|---|---|
| 2026 | 47.09% | 8.42% |
| 2027 | 48.15% | 2.25% |
| 2028 | 48.89% | 1.54% |
| 2029 | 48.62% | 0.55% |
| 2030 | 47.99% | 1.30% |
18 Paychex Analysts have issued a net profit forecast 2026. The average Paychex net profit estimate is $2.0b . This is 24.07% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.1b 28.56% , the lowest is $1.9b 18.62% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $1.7b | 1.96% |
|---|---|---|
| 2026 | $2.0b | 20.81% |
| 2027 | $2.2b | 8.24% |
| 2028 | $2.3b | 6.45% |
| 2029 | $2.5b | 8.53% |
| 2030 | $2.7b | 6.16% |
| 2025 | 29.74% | 7.12% |
|---|---|---|
| 2026 | 30.03% | 0.96% |
| 2027 | 30.64% | 2.03% |
| 2028 | 30.82% | 0.59% |
| 2029 | 31.41% | 1.91% |
| 2030 | 31.61% | 0.64% |
18 Analysts have issued a Paychex forecast for earnings per share. The average Paychex EPS is $5.56 . This is 24.94% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.76 29.44% , the lowest is $5.32 19.55% .
This results in the following potential growth metrics and future valuations:
| 2025 | $4.58 | 1.93% |
|---|---|---|
| 2026 | $5.56 | 21.40% |
| 2027 | $6.02 | 8.27% |
| 2028 | $6.41 | 6.48% |
| 2029 | $6.96 | 8.58% |
| 2030 | $7.38 | 6.03% |
| Current | 28.45 | 5.72% |
|---|---|---|
| 2026 | 22.76 | 20.00% |
| 2027 | 21.03 | 7.60% |
| 2028 | 19.75 | 6.09% |
| 2029 | 18.20 | 7.85% |
| 2030 | 17.14 | 5.82% |
Based on analysts' sales estimates for 2026, the Paychex stock is valued at an EV/Sales of 7.33 and an P/S ratio of 6.83 .
This results in the following potential growth metrics and future valuations:
| Current | 8.43 | 10.89% |
|---|---|---|
| 2026 | 7.33 | 13.07% |
| 2027 | 6.91 | 5.73% |
| 2028 | 6.53 | 5.52% |
| 2029 | 6.13 | 6.07% |
| 2030 | 5.81 | 5.21% |
| Current | 7.87 | 17.99% |
|---|---|---|
| 2026 | 6.83 | 13.12% |
| 2027 | 6.44 | 5.73% |
| 2028 | 6.09 | 5.52% |
| 2029 | 5.72 | 6.07% |
| 2030 | 5.42 | 5.21% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 20 2025 |
| Stephens & Co. |
➜
Equal-Weight
|
Initiated | Oct 07 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 01 2025 |
| BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Oct 01 2025 |
| Stifel |
Hold
➜
Hold
|
Unchanged | Sep 22 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Sep 17 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Aug 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 20 2025 |
|
Initiated
Stephens & Co.:
➜
Equal-Weight
|
Oct 07 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 01 2025 |
|
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Oct 01 2025 |
|
Unchanged
Stifel:
Hold
➜
Hold
|
Sep 22 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Sep 17 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Aug 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


